Evidence map›Paper›PMID 33074714›Full record

SynthesisCancer control : journal of the Moffitt Cancer Center

Survival Rate of Colorectal Cancer in Eastern Mediterranean Region Countries: A Systematic Review and Meta-Analysis.

Hossein-Ali Nikbakht, Soheil Hassanipour, Layla Shojaie, Mohebat Vali, Saber Ghaffari-Fam, Mousa Ghelichi-Ghojogh, Zahra Maleki, Morteza Arab-Zozani, Elham Abdzadeh, Hamed Delam and 3 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. New Insights Into the Anticancer Effects ofDose-response : a publication of International Hormesis Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hossein-Ali NikbakhtSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Soheil HassanipourGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Layla ShojaieDivision of GI/Liver, Department of Medicine, Keck school of Medicine, University of Southern California, Los Angeles, CA, USA.
Mohebat ValiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Saber Ghaffari-FamSchool of Nursing of Miyandoab, Urmia University of Medical Sciences, Urmia, Iran.
Mousa Ghelichi-GhojoghStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra MalekiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Morteza Arab-ZozaniSocial Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Elham AbdzadehGI Cancer Screening and Prevention Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Hamed DelamStudent Research Committee, Larestan University of Medical Sciences, Larestan, Iran.
Hamid SalehiniyaSocial Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Maryam ShafieeAssistant Professor of Medicine, Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Salman MohammadiNutrition Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0003-4841-7975

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide. Survival rates are among the most important factors in quality control and assessment of treatment protocols. This study was aimed to assess the survival rate of colorectal cancer in Eastern Mediterranean Region Countries. In the present study we comprehensively searched 6 international databases including PubMed/Medline, ProQuest, Scopus, Embase, Web of Knowledge and Google Scholar for published articles until November 2018. The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was applied to evaluate the quality of included studies. The heterogeneity of papers was assessed with the Cochran Test and I-Square statistics. Meta-regression test was performed based on publication year, sample size and Human Development Index (HDI) of each study. Among the total of 1023 titles found in the systematic search, 43 studies were eligible to be included in the present meta-analysis. According to the results, the 1-year, 3-year and 5-year survival rate of patients with Colorectal Cancer was 88.07% (95% CI, 83.22-92.92), 70.67% (95% CI, 66.40-74.93) and, 57.26% (95% CI, 50.43-64.10); respectively. Furthermore, Meta-regressions did not show significant correlations between survival rate and year, sample size or Human Development Index. Survival rates, especially the 5-year survival rate in the EMRO were less than European countries and the USA. Documented and comprehensive evidence-based findings of the present meta-analysis can be used to enhance policies and outcomes of different medical areas including prophylaxis, treatment and health related objectives in colorectal cancer.

Indexed as

Cohort StudiesColorectal NeoplasmsEarly Detection of CancerHumansMediterranean RegionPrognosisSurvival Ratecolorectal cancerEMROmeta-analysissurvivalsystematic review

Identifiers

PMID33074714
PMCPMC7791530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.